Sources | Names Used |
---|---|
CTRPv2 | BRD-K61166597 |
PharmacoGx | BRD-K61166597 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDFY1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | TLX2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
mRNA | AL135787.1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | CHAF1B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | NAA50 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | CTSA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SRRD | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | BBS5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | TYROBP | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |